Author Question: After restructuring, your division has had trouble filling the open positions with appropriate ... (Read 96 times)

fbq8i

  • Hero Member
  • *****
  • Posts: 527
After restructuring, your division has had trouble filling the open positions with appropriate candidates. The selection processes used by human resources have not yet adjusted to the new criteria required for the restructured job positions.
 
  This problem is an example of which kind of resistance to change?
  A) structural inertia
  B) limited focus of change
  C) group inertia
  D) threat to expertise
  E) threat to established power relationships

Question 2

What is competitor intelligence? Identify some of the sources of competitor intelligence. Discuss the legal and ethical issues related to this concept.
 
  What will be an ideal response?


mohan

  • Sr. Member
  • ****
  • Posts: 362
Answer to Question 1

A
Explanation: A) This is an example of structural inertia. Organizations have built-in mechanisms, such as their selection processes and formalized regulations, to produce stability. When an organization is confronted with change, this structural inertia acts as a counterbalance to sustain stability.

Answer to Question 2

Answer: Competitor intelligence involves gathering information about competitors that allows managers to anticipate competitors' actions rather than merely react to them. It is one of the fastest-growing forms of environmental scanning. It seeks basic information about competitors: Who are they? What are they doing? How will what they're doing affect us?
Advertisements, promotional materials, press releases, reports filed with government agencies,
annual reports, want ads, newspaper reports, information on the Internet, and industry
studies are readily accessible sources of information. Specific information on an industry
and associated organizations is increasingly available through electronic databases.
Managers can literally tap into this wealth of competitor information by purchasing access
to databases. Attending trade shows and debriefing your own sales staff also can be good
sources of information on competitors. In addition, many organizations even regularly buy
competitors' products and ask their own employees to evaluate them to learn about new
technical innovations.
Managers do need to be careful about the way information, especially competitor intelligence, is gathered to prevent any concerns about whether it's legal or ethical. Difficult decisions about competitor intelligence arise because often there's a fine line between what's considered legal and ethical and what's considered legal but unethical. Some people or companies will go to any lengths some unethical  to get information about competitors. Many who study competitor intelligence suggest that much of the competitor-related information managers need to make crucial strategic decisions that are available and accessible to the public. In other words, competitor intelligence isn't corporate espionage.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

Studies show that systolic blood pressure can be significantly lowered by taking statins. In fact, the higher the patient's baseline blood pressure, the greater the effect of statins on his or her blood pressure.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library